EGFR and malignant colon neoplasm: Specifically, EGCG prevents the activation of the epidermal growth factor receptor (EGFR), the human epidermal growth factor receptor 2 (HER2), and a number of other signaling pathways that are downstream in colon cancer cell lines [12,51].